Details of the Drug

General Information of Drug (ID: DMOCO1F)

• Drug Name: PF-07307405

Indication

Disease Entry	ICD 11	Status	REF
Lyme disease	1C1G	Phase 3	[1]

• Drug Type: Vaccine
• Cross-matching ID: TTD ID: D4LD9G

References

• [1] ClinicalTrials.gov (NCT05634811) A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, OBSERVER-BLINDED TRIAL TO EVALUATE THE SAFETY OF A 6-VALENT OspA-BASED LYME DISEASE VACCINE (VLA15) IN HEALTHY CHILDREN 5 THROUGH 17 YEARS OF AGE. U.S.National Institutes of Health.